Cargando…

Cost–effectiveness of screening for active cases of tuberculosis in Flanders, Belgium

OBJECTIVE: To assess the cost–effectiveness of the tuberculosis screening activities currently funded by the Flemish government in Flanders, Belgium. METHODS: After estimating the expenses for 2013–2014 of each of nine screening components – which include high-risk groups, contacts and people who ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Smit, G Suzanne A, Apers, Ludwig, Arrazola de Onate, Wouter, Beutels, Philippe, Dorny, Pierre, Forier, An-Marie, Janssens, Kristien, Macq, Jean, Mak, Ruud, Schol, Sandrina, Wildemeersch, Dirk, Speybroeck, Niko, Devleesschauwer, Brecht
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Health Organization 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5180339/
https://www.ncbi.nlm.nih.gov/pubmed/28053362
http://dx.doi.org/10.2471/BLT.16.169383
_version_ 1782485513446359040
author Smit, G Suzanne A
Apers, Ludwig
Arrazola de Onate, Wouter
Beutels, Philippe
Dorny, Pierre
Forier, An-Marie
Janssens, Kristien
Macq, Jean
Mak, Ruud
Schol, Sandrina
Wildemeersch, Dirk
Speybroeck, Niko
Devleesschauwer, Brecht
author_facet Smit, G Suzanne A
Apers, Ludwig
Arrazola de Onate, Wouter
Beutels, Philippe
Dorny, Pierre
Forier, An-Marie
Janssens, Kristien
Macq, Jean
Mak, Ruud
Schol, Sandrina
Wildemeersch, Dirk
Speybroeck, Niko
Devleesschauwer, Brecht
author_sort Smit, G Suzanne A
collection PubMed
description OBJECTIVE: To assess the cost–effectiveness of the tuberculosis screening activities currently funded by the Flemish government in Flanders, Belgium. METHODS: After estimating the expenses for 2013–2014 of each of nine screening components – which include high-risk groups, contacts and people who are seeking tuberculosis consultation at a centre for respiratory health care – and the associated costs per active case of tuberculosis identified between 2007 and 2014, we compared the cost–effectiveness of each component. The applied perspective was that of the Flemish government. FINDINGS: The three most cost-effective activities appeared to be the follow-up of asylum seekers who were found to have abnormal X-rays in initial screening at the Immigration Office, systematic screening in prisons and contact investigation. The mean costs of these activities were 5564 (95% uncertainty interval, UI: 3791–8160), 11 603 (95% UI: 9010–14 909) and 13 941 (95% UI: 10 723–18 201) euros (€) per detected active case, respectively. The periodic or supplementary initial screening of asylum seekers and the screening of new immigrants from high-incidence countries – which had corresponding costs of €51 813 (95% UI: 34 855–76 847), €126 236 (95% UI: 41 984–347 822) and €418 359 (95% UI: 74 975–1 686 588) – appeared much less cost-effective. Between 2007 and 2014, no active tuberculosis cases were detected during screening in the juvenile detention centres. CONCLUSION: In Flanders, tuberculosis screening in juvenile detention centres and among new immigrants and the periodic or supplementary initial screening of asylum seekers appear to be relatively expensive ways of detecting people with active tuberculosis.
format Online
Article
Text
id pubmed-5180339
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher World Health Organization
record_format MEDLINE/PubMed
spelling pubmed-51803392017-01-05 Cost–effectiveness of screening for active cases of tuberculosis in Flanders, Belgium Smit, G Suzanne A Apers, Ludwig Arrazola de Onate, Wouter Beutels, Philippe Dorny, Pierre Forier, An-Marie Janssens, Kristien Macq, Jean Mak, Ruud Schol, Sandrina Wildemeersch, Dirk Speybroeck, Niko Devleesschauwer, Brecht Bull World Health Organ Research OBJECTIVE: To assess the cost–effectiveness of the tuberculosis screening activities currently funded by the Flemish government in Flanders, Belgium. METHODS: After estimating the expenses for 2013–2014 of each of nine screening components – which include high-risk groups, contacts and people who are seeking tuberculosis consultation at a centre for respiratory health care – and the associated costs per active case of tuberculosis identified between 2007 and 2014, we compared the cost–effectiveness of each component. The applied perspective was that of the Flemish government. FINDINGS: The three most cost-effective activities appeared to be the follow-up of asylum seekers who were found to have abnormal X-rays in initial screening at the Immigration Office, systematic screening in prisons and contact investigation. The mean costs of these activities were 5564 (95% uncertainty interval, UI: 3791–8160), 11 603 (95% UI: 9010–14 909) and 13 941 (95% UI: 10 723–18 201) euros (€) per detected active case, respectively. The periodic or supplementary initial screening of asylum seekers and the screening of new immigrants from high-incidence countries – which had corresponding costs of €51 813 (95% UI: 34 855–76 847), €126 236 (95% UI: 41 984–347 822) and €418 359 (95% UI: 74 975–1 686 588) – appeared much less cost-effective. Between 2007 and 2014, no active tuberculosis cases were detected during screening in the juvenile detention centres. CONCLUSION: In Flanders, tuberculosis screening in juvenile detention centres and among new immigrants and the periodic or supplementary initial screening of asylum seekers appear to be relatively expensive ways of detecting people with active tuberculosis. World Health Organization 2017-01-01 2016-11-03 /pmc/articles/PMC5180339/ /pubmed/28053362 http://dx.doi.org/10.2471/BLT.16.169383 Text en (c) 2017 The authors; licensee World Health Organization. This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (http://creativecommons.org/licenses/by/3.0/igo/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.
spellingShingle Research
Smit, G Suzanne A
Apers, Ludwig
Arrazola de Onate, Wouter
Beutels, Philippe
Dorny, Pierre
Forier, An-Marie
Janssens, Kristien
Macq, Jean
Mak, Ruud
Schol, Sandrina
Wildemeersch, Dirk
Speybroeck, Niko
Devleesschauwer, Brecht
Cost–effectiveness of screening for active cases of tuberculosis in Flanders, Belgium
title Cost–effectiveness of screening for active cases of tuberculosis in Flanders, Belgium
title_full Cost–effectiveness of screening for active cases of tuberculosis in Flanders, Belgium
title_fullStr Cost–effectiveness of screening for active cases of tuberculosis in Flanders, Belgium
title_full_unstemmed Cost–effectiveness of screening for active cases of tuberculosis in Flanders, Belgium
title_short Cost–effectiveness of screening for active cases of tuberculosis in Flanders, Belgium
title_sort cost–effectiveness of screening for active cases of tuberculosis in flanders, belgium
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5180339/
https://www.ncbi.nlm.nih.gov/pubmed/28053362
http://dx.doi.org/10.2471/BLT.16.169383
work_keys_str_mv AT smitgsuzannea costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium
AT apersludwig costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium
AT arrazoladeonatewouter costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium
AT beutelsphilippe costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium
AT dornypierre costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium
AT forieranmarie costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium
AT janssenskristien costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium
AT macqjean costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium
AT makruud costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium
AT scholsandrina costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium
AT wildemeerschdirk costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium
AT speybroeckniko costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium
AT devleesschauwerbrecht costeffectivenessofscreeningforactivecasesoftuberculosisinflandersbelgium